Business Description
Provexis PLC
ISIN : GB00B0923P27
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
PXS.UKNZCA.Germany IPO Date
2021-03-31Description
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 1.36 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 29.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.05 | |||||
9-Day RSI | 60.42 | |||||
14-Day RSI | 57.49 | |||||
3-1 Month Momentum % | 9.09 | |||||
6-1 Month Momentum % | -7.69 | |||||
12-1 Month Momentum % | 100 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.65 | |||||
Quick Ratio | 3.45 | |||||
Cash Ratio | 2.26 | |||||
Days Inventory | 109.83 | |||||
Days Sales Outstanding | 56.15 | |||||
Days Payable | 197.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | -2.15 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.25 | |||||
Operating Margin % | -70.49 | |||||
Net Margin % | -69.35 | |||||
EBITDA Margin % | -70.49 | |||||
FCF Margin % | -62.83 | |||||
OCF Margin % | -62.83 | |||||
ROE % | -54.45 | |||||
ROA % | -67.71 | |||||
ROIC % | -351.42 | |||||
3-Year ROIIC % | -757.12 | |||||
ROC (Joel Greenblatt) % | -697.73 | |||||
ROCE % | -106.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 11.65 | |||||
PB Ratio | 11.65 | |||||
EV-to-EBIT | -42.79 | |||||
EV-to-EBITDA | -42.79 | |||||
EV-to-Revenue | 30.16 | |||||
EV-to-FCF | -48.12 | |||||
Earnings Yield (Greenblatt) % | -2.34 | |||||
FCF Yield % | -2 |
GF Valueâ„¢
Provexis PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Provexis PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-12-31 | In 136 days | ||
| General meeting for 2026 | 2026-11-20 12:30 | In 96 days | ||
| Annual report for 2026 | 2026-10-30 | In 74 days | ||
| Fourth quarter earnings results for 2026 | 2026-10-30 | In 74 days | ||
| Second quarter earnings results for 2026 | 2025-12-31 | 0.01 (+0.00%) | ||
| General meeting for 2025 | 2025-11-21 12:30 | 0.00 (-66.67%) | ||
| Annual report for 2025 | 2025-10-30 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2025-10-30 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2024-12-31 | 0.00 (-60.00%) | ||
| General meeting for 2024 | 2024-10-25 12:30 | 0.00 (-75.00%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Provexis PLC
No articles.